The White House on Thursday announced that it has finalized negotiations with the manufacturers of the 10 drugs selected for the first round of drug price negotiation under the Biden Administration’s Inflation Reduction Act of 2022 (IRA), which the Administration said will save $1.5 billion in out-of-pocket costs for prescription drugs for people on Medicare and will save Medicare $6 billion “in the first year alone.”
Recent Posts
- Fox Succeeds in Scrapping Machine Learning Claims at CAFC Under 101
- Other Barks & Bites for Friday, April 18: CAFC Affirms Ineligibility of Machine Learning Claims; EPO’s Campinos Issues Opinion on Intervener Appeals; USPTO Ends Climate Change Mitigation Program
- In Latest Antitrust Blow for Google, Judge Finds Search Giant Monopolizes Certain Ad Tech Markets
- New USPTO Group to Crack Down on Threats to U.S. Patent System
- IP, Globalization and the Future of Supply Chains: A Conversation with Sonja London | IPWatchdog Unleashed